clinical trial · NCT03905798
LORA-PITA IV General Investigation
Pfizer·—·completed·n = 206
Status EpilepticusLorazepam
brief summary
Secondary Data Collection:To confirm the effectiveness and safety profiles under the actual medical practice of LORA-PITA in Japan.
started
Nov 18, 2019
primary completion
Nov 15, 2023
completion
Nov 15, 2023
last updated
Mar 10, 2025
detailed description
To confirm the effectiveness and safety profiles under the actual medical practice of LORA-PITA for Status Epilepticus patients in Japan.
official title
LORA-PITA (REGISTERED) Intravenous Injection 2 mg General Investigation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol